UnitedHealth Group Incorporated $UNH Shares Purchased by Bank of New York Mellon Corp

Bank of New York Mellon Corp grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.2% in the 1st quarter, Holdings Channel.com reports. The fund owned 10,088,271 shares of the healthcare conglomerate’s stock after purchasing an additional 931,037 shares during the quarter. UnitedHealth Group makes up about 0.5% of Bank of New York Mellon Corp’s holdings, making the stock its 28th largest position. Bank of New York Mellon Corp’s holdings in UnitedHealth Group were worth $2,729,785,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of UNH. Nordea Investment Management AB lifted its stake in UnitedHealth Group by 4.2% during the fourth quarter. Nordea Investment Management AB now owns 91,496 shares of the healthcare conglomerate’s stock worth $30,287,000 after purchasing an additional 3,720 shares during the last quarter. Vaughan David Investments LLC IL raised its holdings in shares of UnitedHealth Group by 2.7% during the fourth quarter. Vaughan David Investments LLC IL now owns 150,773 shares of the healthcare conglomerate’s stock worth $49,772,000 after purchasing an additional 3,934 shares during the period. Fideuram Intesa Sanpaolo Private Banking S.P.A. grew its position in shares of UnitedHealth Group by 1,287.2% during the 1st quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate’s stock valued at $16,241,000 after buying an additional 55,695 shares during the last quarter. Kensington Investment Counsel LLC bought a new position in UnitedHealth Group in the third quarter worth about $2,888,000. Finally, J. Safra Sarasin Holding AG grew its holdings in shares of UnitedHealth Group by 127.6% during the fourth quarter. J. Safra Sarasin Holding AG now owns 34,947 shares of the healthcare conglomerate’s stock valued at $11,536,000 after purchasing an additional 19,591 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Truist raised its price target on UnitedHealth Group to $480 and maintained a buy rating, signaling confidence in further upside ahead of earnings. UnitedHealth Group (NYSE:UNH) Price Target Raised to $480.00 at Truist Financial
• Positive Sentiment: KeyCorp lifted its price target to $475 and kept an overweight rating, adding to the bullish analyst backdrop for UNH. UnitedHealth Group had its price target raised by KeyCorp from $400.00 to $475.00.
• Positive Sentiment: Zacks Research upgraded UnitedHealth to strong-buy and nudged up future EPS estimates, reinforcing expectations that the company can beat earnings again. UnitedHealth Group was upgraded by Zacks Research from hold to strong-buy.
• Positive Sentiment: Analysts have been raising earnings forecasts for UnitedHealth, and several reports argue the company has a strong chance to top Q2 expectations based on its historical surprise record and favorable earnings setup. Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report?
• Neutral Sentiment: UNH is scheduled to report second-quarter results on July 16, so trading is being driven in part by positioning ahead of the earnings release. UnitedHealth Stock Forecast: Piper Sandler Analyst and Technical Indicators Point to Upside Ahead of Q2 Earnings
• Neutral Sentiment: Technical indicators and some market commentary suggest the stock may have room to move higher after earnings, but this is still contingent on the actual results and outlook. UnitedHealth Reports Earnings Thursday. Here’s How Much Its Stock Is Seen Moving
• Negative Sentiment: Broader managed-care stocks sold off after Elevance Health highlighted margin pressure and weak Medicaid-spending trends, which could weigh on sentiment toward UnitedHealth ahead of its report. Why Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Next

UnitedHealth Group Trading Down 1.8%

Shares of UNH stock opened at $417.33 on Thursday. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The stock has a 50-day simple moving average of $402.80 and a 200 day simple moving average of $341.04. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $434.30. The stock has a market capitalization of $378.99 billion, a P/E ratio of 31.52, a P/E/G ratio of 1.70 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company had revenue of $111.65 billion during the quarter, compared to analyst estimates of $109.84 billion. During the same quarter last year, the firm posted $7.20 EPS. The business’s revenue for the quarter was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 18.39 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were issued a $2.32 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Monday, June 15th. UnitedHealth Group’s dividend payout ratio is currently 70.09%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of analyst reports. Morgan Stanley boosted their price objective on UnitedHealth Group from $453.00 to $468.00 and gave the company an “overweight” rating in a research report on Tuesday, June 30th. Cantor Fitzgerald restated an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, June 11th. Raymond James Financial upgraded shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price objective on the stock in a research report on Wednesday, April 1st. Jefferies Financial Group upped their target price on shares of UnitedHealth Group from $340.00 to $373.00 and gave the stock a “buy” rating in a research report on Monday, April 20th. Finally, Oppenheimer lifted their price target on UnitedHealth Group from $385.00 to $405.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $429.50.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. This trade represents a 4.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.28% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.